Presentation TCT 2013 TCT-8. 6-month versus 12-month dual antiplatelet therapy after implantation of 2nd generation drug-eluting stents with Biolimus-eluting Versus Zotarolimus-eluting stent:... Presenter: Byoung Kwon Lee October 29, 2013
Presentation TCT 2013 Critical Appraisal of the Frequency, Etiology, and Impact of TAVR Complications Presenter: Philippe Généreux October 29, 2013
Presentation TCT 2013 Subintimal CTO Angioplasty with No Reflow and the Rescue Technique Presenter: Damras Tresukosol October 29, 2013
Presentation TCT 2013 Refining the Retrograde Technique: Technical and Regulatory Aspects Presenter: Amit Patel October 29, 2013
Presentation TCT 2013 TCT-73. Forward-Looking IVUS: Technology Overview and First-in-human Case Review Presenter: Carlos Mena October 29, 2013
Presentation TCT 2013 TCT-118. A Multidisciplinary, Multimodality, But Minimalist (3M) Approach To Transfemoral Transcatheter Aortic Valve Replacement Facilitates Safe Next Day Discharge In High Risk... Presenter: David Wood October 29, 2013
Presentation My Best and Worst Cases Involving Coronary Calcification Presenter: Mark Reisman October 29, 2013
Presentation TCT 2013 What would an outcomes trial comparing FFR for all lesions versus a hybrid approach (resting index plus selective FFR) look like? Presenter: Nils P. Johnson October 29, 2013
Presentation TCT 2013 TCT-117. Quality of Life Outcomes Among High-Risk Patients Undergoing TAVR via the Transapical Approach: A PARTNER Continued Access Substudy Presenter: Ajay Kirtane October 29, 2013